HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 436 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2020. The put-call ratio across all filers is 1.02 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $197,858,938 | -20.6% | 1,710,251 | -29.4% | 0.10% | -15.1% |
Q2 2023 | $249,278,883 | +4.8% | 2,423,713 | +11.2% | 0.12% | 0.0% |
Q1 2023 | $237,808,638 | +78.9% | 2,178,932 | +86.6% | 0.12% | +72.5% |
Q4 2022 | $132,895,298 | +2.5% | 1,167,797 | -44.2% | 0.07% | -2.8% |
Q3 2022 | $129,622,000 | -17.1% | 2,094,406 | +6.8% | 0.07% | -9.0% |
Q2 2022 | $156,358,000 | -25.6% | 1,960,353 | -1.8% | 0.08% | -7.1% |
Q1 2022 | $210,047,000 | -0.8% | 1,996,461 | +1.6% | 0.08% | +10.5% |
Q4 2021 | $211,690,000 | +3.3% | 1,964,447 | +5.0% | 0.08% | -1.3% |
Q3 2021 | $204,969,000 | +10.9% | 1,871,181 | -5.2% | 0.08% | +8.5% |
Q2 2021 | $184,742,000 | -4.5% | 1,972,899 | -6.1% | 0.07% | -10.1% |
Q1 2021 | $193,369,000 | +31.4% | 2,100,928 | +4.4% | 0.08% | +27.4% |
Q4 2020 | $147,136,000 | -5.2% | 2,011,435 | +0.7% | 0.06% | -17.3% |
Q3 2020 | $155,146,000 | +94.7% | 1,997,236 | +50.5% | 0.08% | +82.9% |
Q2 2020 | $79,686,000 | – | 1,326,982 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |